Cardiovascular & Hematological Agents in Medicinal Chemistry

The No-Reflow Phenomenon in the Coronary Circulation
pp. 181-192(12)
Authors: Kiernan, Thomas J.; Ruggiero II, Nicholas J.; Bernal, Juan M.; Don, Creighton W.; Witzke, Christian; Kiernan, Gareth D.; Cubeddu, Roberto J.; Yan, Bryan P.

Anticoagulation in Patients with Heart Failure
pp. 193-197(5)
Authors: Bhatia, R. S.; Ouzounian, Maral; Tu, Jack V.; Liu, Peter P.; Lee, Douglas S.

Optimal Management of Hypertension in patients with Ischemic Heart Disease
pp. 198-205(8)
Authors: Mukherjee, Debabrata; Campbell, Charles L.

Phosphodiesterase 3 (PDE3): Structure, Localization and Function
pp. 206-211(6)
Authors: Murata, Taku; Shimizu, Kasumi; Hiramoto, Kenichi; Tagawa, Toshiro

Current Pharmacological Approach to Restore Endothelial Dysfunction
pp. 212-222(11)
Authors: Dobarro, D.; Gomez-Rubin, M. C.; Sanchez-Recalde, A.; Moreno, R.; Galeote, G.; Jimenez-Valero, S.; Calvo, L.; de Sa, E. L.; Lopez-Sendon, J. L.

Respiratory Syncytial Virus (RSV) Prevention and Treatment: Past, Present, and Future
pp. 223-233(11)
Author: Weisman, Leonard E.

Human Plasma Kallikrein-Kinin System: Physiological and Biochemical Parameters
pp. 234-250(17)
Authors: Bryant, J. W.; Shariat-Madar, Z.

The C242T CYBA Polymorphism as a Major Determinant of NADPH Oxidase Activity in Patients with Cardiovascular Disease
pp. 251-259(9)
Authors: Mehranpour, P.; Wang, S. S.; Blanco, R. R.; Li, W.; Song, Q.; Lassegue, B.; Dikalov, S. I.; Austin, H.; Zafari, A. M.